Prascend Tablets contain pergolide for the control of clinical signs associated with Pituitary Pars Intermedia Dysfunction (Equine Cushing’s Disease) in horses. Each Prascend Tablet contains 1 mg pergolide mesylate. Administer orally once daily at the rate directed. Pergolide mesylate.
Prascend Tablet dosing table: 300-749 lbs. body weight: 0.5 to 1 tablet 750-1249 lbs. body weight: 1 to 2 tablets 1250-1749 lbs. body weight: 1.5 to 3 tablets 1750-2249 lbs. body weight: 2 to 4 tablets